title: [Granulomatous prostatitis as collateral effect of intravesical immunotherapy with BCG].
abstract: Twenty-five male patients with superficial bladder cancer underwent intravesical Bacillus Calmette Guerin immunotherapy. A high incidence of side effects has occurred using three different substrains of BCG. Our interest has been focused on BCG related granulomatous prostatitis: we have found four asymptomatic patients with histologically diagnosed disease. We suppose therefore that its incidence is underestimated.
authors.affiliation: Istituto di Anatomia e Istologia Patologica, Università degli Studi di Siena.
authors.forename: F M
authors.initials: FM
authors.lastname: Mattei
authors.forename: V
authors.initials: V
authors.lastname: Giovannelli
authors.forename: L
authors.initials: L
authors.lastname: Schepis
authors.forename: M T
authors.initials: MT
authors.lastname: Del Vecchio
authors.forename: M
authors.initials: M
authors.lastname: Di Renzo
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D001500:BCG Vaccine / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000628:therapy; D006099:Granuloma / Q000209:etiology*; D006801:Humans; D008297:Male; D011472:Prostatitis / Q000209:etiology*; D001749:Urinary Bladder Neoplasms / Q000628:therapy
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine
vernacular_title: Prostatite granulomatosa come effetto collaterale dell'immunoterapia endovescicale con BCG.